Concomitant treatment with systemic and intralesional brentuximab for resistant CD30+ mycosis fungoides lesions.

IF 2 4区医学 Q3 DERMATOLOGY

European Journal of Dermatology Pub Date : 2025-04-01 DOI:10.1684/ejd.2025.4847

Carolina Labrandero-Hoyos, Nidia Planella Fontanillas, David Conde-Esteve, Ramon M Pujol, Blanca Sánchez-González, Fernando Gallardo

引用次数: 0

查看原文本刊更多论文

同时治疗耐药CD30+真菌样皮损的全身和局部布伦妥昔单抗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Dermatology 医学-皮肤病学

CiteScore

2.00

自引率

4.00%

发文量

129

审稿时长

6-12 weeks

期刊介绍： The European Journal of Dermatology is an internationally renowned journal for dermatologists and scientists involved in clinical dermatology and skin biology. Original articles on clinical dermatology, skin biology, immunology and cell biology are published, along with review articles, which offer readers a broader view of the available literature. Each issue also has an important correspondence section, which contains brief clinical and investigative reports and letters concerning articles previously published in the EJD. The policy of the EJD is to bring together a large network of specialists from all over the world through a series of editorial offices in France, Germany, Italy, Spain and the USA.